Evidence map›Paper›PMID 41088344›Full record

ArticleGeneral thoracic and cardiovascular surgery cases2025

Complete thoracoscopic resection for TXN2aM0 primary lung cancer: a case series with 5-year follow-up.

Daiki Yoshikawa, Takeshi Kawaguchi, Ryo Miyata, Keiji Yamanashi, Maiko Takeda, Akihiko Yoshizawa, Takao Osa, Kazuya Tanimura, Shigeto Hontsu, Shigeo Muro and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in General thoracic and cardiovascular surgery cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Daiki YoshikawaDepartment of Thoracic and Cardiovascular Surgery, Nara Medical University, 840 Shijo-Cho, Kashihara, Nara, 634-8511, Japan.
Takeshi KawaguchiDepartment of Thoracic and Cardiovascular Surgery, Nara Medical University, 840 Shijo-Cho, Kashihara, Nara, 634-8511, Japan.
Ryo MiyataDepartment of Thoracic and Cardiovascular Surgery, Nara Medical University, 840 Shijo-Cho, Kashihara, Nara, 634-8511, Japan.
Keiji YamanashiDepartment of Thoracic and Cardiovascular Surgery, Nara Medical University, 840 Shijo-Cho, Kashihara, Nara, 634-8511, Japan.
Maiko TakedaDepartment of Diagnostic Pathology, Nara Medical University, Nara, Japan.
Akihiko YoshizawaDepartment of Diagnostic Pathology, Nara Medical University, Nara, Japan.
Takao OsaDepartment of Respiratory Medicine, Nara Medical University, Kashihara, Japan.
Kazuya TanimuraDepartment of Respiratory Medicine, Nara Medical University, Kashihara, Japan.
Shigeto HontsuDepartment of Respiratory Medicine, Nara Medical University, Kashihara, Japan.
Shigeo MuroDepartment of Respiratory Medicine, Nara Medical University, Kashihara, Japan.
Sachiko MiuraDepartment of Radiation Oncology, Nara Medical University, Kashihara, Japan.
Mitsuharu HosonoDepartment of Thoracic and Cardiovascular Surgery, Nara Medical University, 840 Shijo-Cho, Kashihara, Nara, 634-8511, Japan.
Masatsugu HamajiDepartment of Thoracic and Cardiovascular Surgery, Nara Medical University, 840 Shijo-Cho, Kashihara, Nara, 634-8511, Japan. mhamaji@kuhp.kyoto-u.ac.jp.ORCID http://orcid.org/0000-0002-9808-8260

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Management of resectable TXN2aM0 primary lung cancer is controversial, and data regarding the long-term outcomes and guideline recommendations for such cases are lacking. We present the characteristics and long-term outcomes of four patients who underwent complete thoracoscopic resection of TXN2aM0 primary lung cancer. All patients experienced an uneventful postoperative course and survived for 5 to 10 years postoperatively; however, one patient experienced local recurrence at 2 years postoperatively and one patient experienced local recurrence at 5 years postoperatively. Our limited experience suggested that long-term survival may be achieved with complete resection of TXN2aM0; however, late recurrence and local recurrence are possible.

Indexed as

Lymph node metastasisMediastinal lymphadenopathyPrimary lung cancerSurgeryThoracoscopic resection

Identifiers

PMID41088344
PMCPMC12522338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.